Sign up to save your podcasts
Or
Share Lead: Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Lead: Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
The Lancet Public Health
In this review article, methadone take-home dosing considerations during the COVID-19 pandemic were examined. A search of published research on the flexibility of these practices, patient-provider experience, health outcomes, and how these findings might influence updated regulations was performed. The review found no evidence of increased methadone overdose risk as a result of greater pandemic flexibility. Benefits of such policy include potentially improved treatment retention and impressive improvements in patient quality of life. This is key for SAMHSA as it ponders the steps to make these flexibilities permanent.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
View all episodes
By American Society of Addiction Medicine
4.9
77 ratings
Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
The Lancet Public Health
In this review article, methadone take-home dosing considerations during the COVID-19 pandemic were examined. A search of published research on the flexibility of these practices, patient-provider experience, health outcomes, and how these findings might influence updated regulations was performed. The review found no evidence of increased methadone overdose risk as a result of greater pandemic flexibility. Benefits of such policy include potentially improved treatment retention and impressive improvements in patient quality of life. This is key for SAMHSA as it ponders the steps to make these flexibilities permanent.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
More shows like This Week in Addiction Medicine from ASAM
View all
NEI Podcast
131 Listeners
JAMA Clinical Reviews
480 Listeners
AFP: American Family Physician Podcast
683 Listeners
Frankly Speaking About Family Medicine
256 Listeners
White Coat Investor Podcast
2,412 Listeners
The Curbsiders Internal Medicine Podcast
3,342 Listeners
Core IM | Internal Medicine Podcast
1,093 Listeners
Addiction Medicine: Beyond the Abstract
28 Listeners
Psychopharmacology and Psychiatry Updates
281 Listeners
The Carlat Psychiatry Podcast
552 Listeners
The Curious Clinicians
362 Listeners
The Curbsiders Addiction Medicine Podcast
116 Listeners
Addiction Medicine Journal Club
31 Listeners
PsychRounds: The Psychiatry Podcast
110 Listeners